Tovuti hii inatekeleza vipengele vya msingi kwa sasa na bado haiko tayari kwa matumizi ya wagonjwa.

Chanjo ya Rubella

liveWHO: RUB

Muhtasari

Inalinda dhidi ya rubella (surua ya Kijerumani), maambukizi ya virusi ambayo kwa kawaida ni myepesi lakini hatari sana wakati wa ujauzito, yakisababisha dalili za rubella ya kuzaliwa.

Inalinda dhidi ya rubella (surua ya Kijerumani), maambukizi ya virusi ambayo kwa kawaida ni myepesi lakini hatari sana wakati wa ujauzito, yakisababisha dalili za rubella ya kuzaliwa.

Watoto katika programu ya chanjo za kawaida (kwa kawaida kama chanjo ya MMR), wanawake wa umri wa kuzaa ambao hawajachanjwa.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Severe allergic reaction to previous dose, neomycin, or any component. Pregnancy — live vaccine; avoid conception for ≥4 weeks after vaccination (previously 3 months, revised to 4 weeks based on accumulated safety data). Severe immunodeficiency: symptomatic HIV (CD4 <200), active leukemia/lymphoma, immunosuppressive therapy, congenital immunodeficiency. Moderate to severe acute illness (defer).

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Very common: injection site pain (15–25%). Common: low-grade fever (5–15%), transient rash (5%, typically 7–10 days post-vaccination), lymphadenopathy. Joint symptoms (arthralgia/transient arthritis): 25% in adult women (rare in children and men) — onset 1–3 weeks post-vaccination, self-limiting over days to weeks. Rare: thrombocytopenic purpura (1/25,000), peripheral neuritis. Very rare: chronic arthropathy not confirmed to be causally related.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Single 0.5 mL dose, subcutaneous injection. Part of routine childhood schedule as MMR (12–15 months, 4–6 years). Standalone: single dose for catch-up in non-immune adults. Administered SC in deltoid or anterolateral thigh. Reconstitute lyophilized vaccine with supplied diluent; use within 8 hours.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Single dose: 95–100% seroconversion rate. Immunity is considered lifelong after single dose (unlike measles, rubella antibodies persist reliably). Effectiveness of rubella-containing vaccines: >97% against rubella, near 100% against CRS when vaccinated before pregnancy.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Store at +2°C to +8°C (or -20°C for long-term). Protect from light (photosensitive). Reconstituted vaccine: use within 8 hours, store at +2°C to +8°C. Diluent: do NOT freeze.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Same-day administration with other live vaccines is acceptable (MMR component rule). If not given same day, wait ≥28 days before another live injectable vaccine. Can be given with inactivated vaccines at any interval. Blood products: defer vaccination ≥3 months after immunoglobulin or blood transfusion (may reduce response). Tuberculin skin test: may be suppressed for 4–6 weeks after rubella vaccination.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

CONTRAINDICATED in pregnancy (live vaccine). However, inadvertent vaccination is NOT an indication for pregnancy termination — no confirmed CRS cases from vaccine strain. Advise ≥4 weeks contraception post-vaccination. Breastfeeding: safe (vaccine virus isolated in breast milk but no disease in breastfed infants).

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Part of routine childhood schedule via MMR (12–15 months + 4–6 years). Standalone rubella vaccine: limited pediatric use; prefer MR or MMR. Children ≥6 months: can receive MMR early for outbreak protection (dose before 12 months does not count for routine series).

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Advise women of childbearing age to avoid pregnancy for ≥4 weeks post-vaccination. If inadvertently given in pregnancy, counsel that registry data shows NO confirmed cases of CRS from vaccine strain (CDC registry: >1,000 susceptible women vaccinated in early pregnancy with 0 CRS cases). Rubella vaccination during pregnancy is NOT an indication for termination. Standalone rubella vaccine is being phased out globally in favor of MR (measles-rubella) or MMR.

Madhara

Ya kawaida sana

Maumivu ya viungo

Ya kawaida

Homa
Upele wa jumla
Maumivu kwenye eneo la sindano
Kuvimba kwa tezi za limfu

Vizuizi

TahadhariUgonjwa mkali wa papo hapo na homa
KamiliMshituko mkali baada ya dozi ya awali
KamiliMzio kwa kijenzi cha chanjo
TahadhariMzio wa neomycin
KamiliUjauzito (chanjo za vijidudu hai)
TahadhariUpokeaji wa hivi karibuni wa bidhaa za damu
KamiliUpungufu mkubwa wa kinga mwilini

Ratiba ya chanjo

Hakuna data ya ratiba inayopatikana.

Inalinda dhidi ya

Surua ya Ujerumani (Rubella)(2)

Dalili

Pata chanjo kabla ya safari yako

Unajua chanjo unayohitaji? Vizuri. Hujui? Tuambie tu unaenda wapi — tutapata chanjo zinazofaa na kliniki. Bure, bila masharti.

Maudhui katika ukurasa huu ni kwa madhumuni ya habari na elimu pekee. Hayaundi ushauri wa kitabibu, utambuzi, au mapendekezo ya matibabu. Ikiwa una wasiwasi wa kiafya, wasiliana na mtaalamu wa afya aliyeidhinishwa. Medova si mtoa huduma za matibabu.

Masharti kamili ya matumizi